Stricture Definition and Treatment (STRIDENT) Observational Study.
NCT ID: NCT03218202
Last Updated: 2019-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
9 participants
OBSERVATIONAL
2017-10-09
2019-08-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study
NCT03222011
Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
NCT03220841
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031
Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures
NCT06203782
Endoscopic Stricturotomy Versus Endoscopic Balloon Dilatation in Patients With Crohn's Disease and Symptomatic Small Bowel Stricture
NCT05009212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Evidence of dysplasia or malignancy from stricture biopsies or adjacent mucosal biopsies
* Patients for whom endoscopy is not suitable due to co-morbidities or clinical state
* Inability to give informed consent
* Suspected perforation of the gastrointestinal tract
* Inability to undergo MRI small bowel due to a contraindication.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Australasian Gastro Intestinal Research Foundation
OTHER
St Vincent's Hospital Melbourne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Kamm
Professor of Gastroenterology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Wright, MBBS PhD
Role: PRINCIPAL_INVESTIGATOR
St Vincent's Hospital Melbourne
Bronte Holt, MBBS PhD
Role: PRINCIPAL_INVESTIGATOR
St Vincent's Hospital Melbourne
Michael Kamm, MBBS PhD
Role: PRINCIPAL_INVESTIGATOR
St Vincent's Hospital Melbourne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Vincent's Hospital Melbourne
Melbourne, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SVHMelbourneSTRIDENT3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.